Last reviewed · How we verify

NCT07208851

Developing a Booster Session for Problem Management Plus in the Bahamas: A Pilot Randomized Controlled Trial

Recruiting now NA Last updated 6 January 2026
What this trial tests

NA trial testing Problem Management Plus booster session in Depression Symptoms in 50 participants. Currently enrolling.

Timeline
16 October 2024
Primary endpoint
31 July 2026
31 July 2026

Quick facts

Lead sponsorThe New School
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date16 October 2024
Primary completion31 July 2026
Estimated completion31 July 2026
Sites1 location across The Bahamas

Drugs / interventions tested

Conditions studied

Sponsor

The New School

Who can join

18 and older, any sex, with Depression Symptoms or Anxiety Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Therapists at the Grand Bahama Resilience Center (GBRC) will be trained to deliver Problem Management Plus (PM+), a WHO intervention. Then, those therapists will deliver PM+ (5 one-on-one skills-based sessions) to a total of 50 adult clients experiencing mild to moderate mental health difficulties (excluding anyone with cognitive difficulties or psychosis). Participants will complete (de-identified) self-report survey assessments before PM+, after PM+, 3 months later, and 6 months later. After receiving 5 sessions of PM+, participants will be randomized to either receive a one-time booster session of PM+ (to be co-created by the PI and the GBRC providers) three months later or to a control group which will receive a phone call reminding them that they will receive their third assessment soon.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression Symptoms

Currently open trials in the same condition.

Other The New School trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07208851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing